Avalo Therapeutics
AVTX
AVTX
20 hedge funds and large institutions have $84.7M invested in Avalo Therapeutics in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
4
Reduced
2
Closed
4
Calls
$152K
Puts
–
Net Calls
+$152K
Net Calls Change
+$148K
Top Buyers
1 |
AC
Armistice Capital
New York
|
+$5.08M |
2 |
Invesco
Atlanta,
Georgia
|
+$321K |
3 |
Millennium Management
New York
|
+$292K |
4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$169K |
5 |
Goldman Sachs
New York
|
+$81K |